Market Place
Sourcing Support
Bristol Myers Squibb Showcases Cardiovascular Data at AHA 2024
11 Nov 2024 //
BUSINESSWIRE
Bristol Myers Squibb To Present Cardiovascular Data At ECS 2024
27 Aug 2024 //
INDIANPHARMAPOST
Pfizer tacks on $1B to 2024 revenue outlook amid cost-cutting drive
31 Jul 2024 //
PRESS RELEASE
Abecma competition, Sotyktu pricing pressure and IRA: Analysts outline BMS
12 Jul 2024 //
FIERCE PHARMA
Pfizer`s chief scientist Mikael Dolsten to step down
09 Jul 2024 //
REUTERS
J&J, Bristol Myers lose challenges to US drug price negotiation program
30 Apr 2024 //
REUTERS
Bristol Myers to cut 6% of workforce, trim drug pipeline
25 Apr 2024 //
BIOPHARMADIVE
Apotex`s Generic Apixaban Receives Approval in the U.S.
16 Feb 2024 //
FDA
Hetero`s Generic Apixaban Receives Approval in the U.S.
21 Nov 2023 //
FDA
ICER weighs in on Eliquis, Xarelto price negotiations at CMS
03 Oct 2023 //
FIERCE PHARMA
US details first 10 drugs subject to Medicare price negotiations
30 Aug 2023 //
REUTERS
Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation
14 Mar 2023 //
REUTERS
Zydus Lifesciences gets USFDA nod to market generic drug
01 Mar 2023 //
HEALTH ET
Anticoagulant unbeneficial for Covid-19 University of Cambridge trial finds
28 Nov 2022 //
CLINICALTRIALSARENA
Tiefenbacher Pharma Successfully Launches Generic Version Apixaban In Canada
20 Oct 2022 //
PRESS RELEASE
CVS resumes coverage of blockbuster blood thinner
28 Jun 2022 //
ENDPTS
CVS Health returns BMS, Pfizer`s Eliquis to formulary
24 Jun 2022 //
FIERCEPHARMA
Teva UK introduces first generic oral anticoagulant
01 Jun 2022 //
PHARMATIMES
BMS refreshes Eliquis campaign, adds eye-catching animations in TV ads
26 May 2022 //
ENDPTS
What To Expect From Bristol Myers Squibb Stock After Q1 Results?
28 Apr 2022 //
FORBES
Eliquis partners BMS, Pfizer double down on heart health
18 Feb 2022 //
FIERCEPHARMA
Sigmapharm`s Generic Apixaban Receives approval in the U.S.
01 Feb 2022 //
FDA
Lilly, BMS drugs join top TV ad spenders in December
27 Jan 2022 //
FIERCEPHARMA
CVS takes a swing at BMS & Pfizer, excluding coverage of Eliquis in 2022
11 Dec 2021 //
ENDPTS
BMS encouraged by uptake of CAR-T treatments Abecma, Breyanzi
27 Oct 2021 //
FIERCEPHARMA
New data in the European Heart Journal show ciraparantag reverses
04 Oct 2021 //
GLOBENEWSWIRE
New data in the European Heart Journal show ciraparantag reverses
04 Oct 2021 //
GLOBENEWSWIRE
Apixaban Drug Market: Rise in prevalence of venous thromboembolism
21 Sep 2021 //
BIOSPACE
Bristol-Myers Squibb gets interim relief against Micro Labs on apixaban
19 Aug 2021 //
PHARMABIZ
Instrumentation Receives Marketing Authorization For Apixaban Diagnostic Test
22 Sep 2020 //
PRNEWSWIRE
Indoco`s Generic Apixaban Receives Approval In US
17 Sep 2020 //
FDA
Indoco gets USFDA nod for apixaban tablets
15 Sep 2020 //
EXPRESS PHARMA
Sigmapharm Labs LLC Generic Apixaban Receives Approval In The US
14 Sep 2020 //
FDA
NICE backs Portola`s Ondexxya
11 Sep 2020 //
PHARMATIMES
NIH spotlights blood thinners; All it took was a pandemic to get JPM out of SF
11 Sep 2020 //
ENDPTS
Sigmapharm Labs`s Generic Apixaban Receives Tentative Approval In US
10 Sep 2020 //
FDA
Pfizer, BMS` Eliquis tops Xarelto, vitamin K drugs for bleeding risks
30 Aug 2020 //
FIERCE PHARMA
Accord Hlthcare’s Generics Apixaban Receives Approval In US
01 Aug 2020 //
FDA
AMAG Announces Presentation of Ciraparantag Data at the International Society
13 Jul 2020 //
MARKETWATCH
New vaccine for Ebola among CHMP recommendations
01 Jun 2020 //
PHARMATIMES
COVID drives demand for BMS` Eliquis but could hurt Opdivo sales
07 May 2020 //
FIERCE PHARMA
Bionpharma`s Generic Apixaban Receives Approval in US
10 Apr 2020 //
FDA
HC Bars Cipla, 3 others from launching generic version of Bristol-Myer`s Drug
10 Jan 2020 //
THE ECONOMIC TIMES
Pfizer, BMS, AbbVie and others raise prices to ring in 2020
03 Jan 2020 //
FIERCE PHARMA
FDA approves first generic of Bristol-Myers, Pfizer`s blood thinner Eliquis
24 Dec 2019 //
REUTERS
Micro Lab`s Generic Caffeine Citrate Receives Approval in US
23 Dec 2019 //
FDA
Mylan`s Generic Apixaban Receives Approval in US
23 Dec 2019 //
FDA
Pfizer, BMS look to early atrial fibrillation screening for potential Eliquis
18 Nov 2019 //
FIERCE PHARMA
What`s at stake for pharma in Pelosi`s pricing plan? Megabillions
12 Sep 2019 //
FIERCE PHARMA
Sunshine Lake Generic Apixaban Receives Tentative Approval in US
11 Sep 2019 //
FDA
Findings Released from NAXOS, a French Real-World Data Analysis
03 Sep 2019 //
PRESS RELEASE
New Pfizer, BMS real-world data could boost Eliquis in Europe
03 Sep 2019 //
FIERCE PHARMA
Bristol-Myers posts strong second quarter earnings as Eliquis, Orencia surprise
26 Jul 2019 //
REUTERS
J&J execs have plenty to brag about pharma. Why downplay Xarelto, Zytiga woes?
16 Jul 2019 //
FIERCE PHARMA
Pfizer`s Xeljanz drops off top June TV spenders list
11 Jul 2019 //
FIERCE PHARMA
Merck`s Keytruda will capture industry`s top sales spot in 2024: report
05 Jun 2019 //
FIERCE PHARMA
UPDATE 3-Vaccine and blood thinner help drive Pfizer to quarterly earnings beat
30 Apr 2019 //
CNBC
Polpharma B2B Announces New Vice-President
25 Mar 2019 //
PHARMACEUTICAL-TECHNOLOGY
First European APIs, Sugammadex and Apixaban, filed to the NMPA
21 Mar 2019 //
PRESS RELEASE
